Literature DB >> 9462405

Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease.

D Nehra1, P Howell, J K Pye, J Beynon.   

Abstract

BACKGROUND: Bile acid reflux is an important component of duodenogastro-oesophageal reflux but there is no effective method of quantifying it. The contribution of bile acids to oesophageal pH is unknown.
METHODS: Oesophageal aspirates were collected over 15 h using a new automated suction device and pH was monitored in ten asymptomatic volunteers (group 1) and 30 patients with reflux oesophagitis (group 2, minimal mucosal injury; group 3, erosive oesophagitis; group 4, stricture or Barrett's oesophagus). Bile acid assay was performed by high-performance liquid chromatography.
RESULTS: The concentration of bile acids was significantly higher in group 3 (median (interquartile range) 124 (50-301) mumol/l) and group 4 (181 (85-591) mumol/l) compared with group 1 (0 mumol/l) and group 2 (14 (0-100) mumol/l). Patients in groups 3 and 4 also had significantly greater DeMeester acid scores. Combined bile acid and oesophageal acid reflux was observed in eight of ten patients with stricture or Barrett's oesophagus. There was no correlation between total bile acid concentration and oesophageal acid or alkaline exposure.
CONCLUSION: This study supports the theory of toxic synergism between acid and bile acids in reflux oesophagitis. Bile acids may contribute to the pathogenesis of Barrett's metaplasia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462405     DOI: 10.1046/j.1365-2168.1998.00533.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Barrett's oesophagus and proton pump inhibitors: a pathological perspective.

Authors:  N A Shepherd
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 2.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.

Authors:  J Theisen; D Nehra; D Citron; J Johansson; J A Hagen; P F Crookes; S R DeMeester; C G Bremner; T R DeMeester; J H Peters
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

4.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

5.  Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux.

Authors:  L Martinez de Haro ; A Ortiz; P Parrilla; V Munitiz; J Molina; J Bermejo; A Rios
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

6.  Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model.

Authors:  C Poplawski; D Sosnowski; A Szaflarska-Popławska; J Sarosiek; R McCallum; Z Bartuzi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 7.  Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.

Authors:  Manuel Pera
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

8.  Effect of cholecystectomy on gastric and esophageal bile reflux in patients with upper gastrointestinal symptoms.

Authors:  Martin Fein; Marco Bueter; Marco Sailer; Karl-Herrmann Fuchs
Journal:  Dig Dis Sci       Date:  2007-10-16       Impact factor: 3.199

9.  Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett's oesophagus by modulating integrin-αv trafficking.

Authors:  David O Prichard; Anne Marie Byrne; James O Murphy; John V Reynolds; Jacintha O'Sullivan; Ronan Feighery; Brendan Doyle; Osama Sharaf Eldin; Stephen P Finn; Aoife Maguire; Deirdre Duff; Dermot P Kelleher; Aideen Long
Journal:  J Cell Mol Med       Date:  2017-09-22       Impact factor: 5.310

10.  Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells.

Authors:  Eileen Looby; Mohamed M M Abdel-Latif; Veronica Athié-Morales; Shane Duggan; Aideen Long; Dermot Kelleher
Journal:  BMC Cancer       Date:  2009-06-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.